Iovance Biotherapeutics Inc (IOVA) Stock Price, Quote & News

Company Profile

Iovance Biotherapeutics, Inc., a commercial-stage biopharmaceutical company, develops and commercializes cell therapies using autologous tumor infiltrating lymphocyte for the treatment of metastatic melanoma and other solid tumor cancers in the United States and internationally. The company offers Amtagvi, an individualized T cell therapy for solid tumor cancer and for the treatment of adult patients with previously treated advanced, or unresectable or metastatic melanomal; and Proleukin, an int...

Industry: Biotechnology

Sector: Healthcare

Phone: 650 260 7120

Website: www.iovance.com

Address:

825 Industrial Road, Suite 100, San Carlos, United States

bigdog85 Aug. 29 at 1:03 AM

$IOVA 🔥

2 · Reply

dogbone98 Aug. 29 at 12:20 AM

$IOVA Checked the IOVA job board and it looks like they filled two Regulatory positions, including Director. Also added 4 production positions.

0 · Reply

sck2 Aug. 28 at 11:15 PM

$IOVA 🕵️‍♂️💪🐂Short answer, Zenel: Yes — this news is legitimately bullish for IOVA. FDA clearance of IOV‑5001 is not just “another trial approval.” It is a strategic expansion of Iovance’s TIL platform into massive new solid‑tumor markets, and it materially strengthens the long‑term valuation story for shareholders. Below is the full, structured breakdown, grounded directly in the search results you triggered.

2 · Reply

Cfl41m Aug. 28 at 10:49 PM

$IOVA

0 · Reply

Cfl41m Aug. 28 at 10:48 PM

$IOVA

0 · Reply

Fire_Truck Aug. 28 at 10:15 PM

$IOVA https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iova/iovance-biotherapeutics/news/iovance-biotherapeutics-iova-wins-fda-trial-clearance-is-the

1 · Reply

FoundMuhMoney Aug. 28 at 9:23 PM

$IOVA Sometimes ya add just to add.. 🤷🏻‍♂️

2 · Reply

dogbone98 Aug. 28 at 8:30 PM

$IOVA Looking at the 6 month graph, next week looks poised to head to either $7 or $9. I'll take flatline too, but don't want 7's.

2 · Reply

JoeBio Aug. 28 at 8:21 PM

$IOVA Soon—and very soon, honestly just one PR away—those frantic, undisciplined traders who sold me their IOVA shares today will be feeling awfully regretful....…I may be wrong, but highly doubt it! We shall see......

2 · Reply

sck2 Aug. 28 at 8:15 PM

$IOVA don't let the stock stop you from celebrating your dinner, jmo and enjoy your weekend.

1 · Reply

Iovance Biotherapeutics price target raised to $10 from $7 at TD Cowen

Aug 21, 2026, 5:15 PM EDT - 7 days ago

Iovance Biotherapeutics Reports Inducement Grants under NASDAQ Listing Rule 5635(c)(4)

2026-08-20T10:15:35.000Z - 8 days ago

Iovance Biotherapeutics price target raised to $7 from $4 at UBS

2026-08-18T11:06:16.000Z - 10 days ago

Iovance Biotherapeutics price target raised to $11 from $10 at Mizuho

2026-08-17T14:55:08.000Z - 11 days ago

Iovance Biotherapeutics put volume heavy and directionally bearish

2026-08-07T11:55:31.000Z - 21 days ago

Iovance Biotherapeutics price target raised to $6 from $4 at Baird

2026-08-07T10:21:31.000Z - 21 days ago

Iovance Biotherapeutics price target raised to $8 from $5 at Citizens

2026-08-07T09:40:45.000Z - 21 days ago

Iovance Biotherapeutics price target raised to $13 from $11 at Barclays

Aug 6, 2026, 8:30 AM EDT - 22 days ago

Iovance Biotherapeutics Earnings Call Transcript: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 22 days ago

Iovance Biotherapeutics Earnings release: Q2 2026

Aug 6, 2026, 8:30 AM EDT - 22 days ago

Iovance Biotherapeutics Quarterly report: Q2 2026

2026-08-06T12:12:53.000Z - 22 days ago

Iovance Biotherapeutics backs FY26 revenue view $350M-370M, consensus $352M

2026-08-06T12:05:43.000Z - 22 days ago

Iovance Biotherapeutics reports Q2 EPS (11c), consensus (13c)

Aug 6, 2026, 7:01 AM EDT - 22 days ago

Iovance Biotherapeutics Reports Record Second Quarter 2026 Revenue of ~$99M, Business Achievements, and Corporate Updates

Jul 30, 2026, 8:00 AM EDT - 4 weeks ago

Iovance Biotherapeutics to Report Second Quarter 2026 Financial Results and Corporate Updates on Thursday, August 6, 2026

Jun 30, 2026, 7:00 AM EDT - 2 months ago

Iovance Biotherapeutics Slides: Corporate presentation

2026-06-18T20:35:12.000Z - 2 months ago

Iovance Biotherapeutics files automatic mixed securities shelf

Jun 10, 2026, 11:00 AM EDT - 2 months ago

Iovance Biotherapeutics Transcript: AGM 2026

Jun 4, 2026, 1:25 PM EDT - 3 months ago

Iovance Biotherapeutics Transcript: Jefferies Global Healthcare Conference 2026

2026-06-03T20:45:39.000Z - 3 months ago

Iovance receives Australian approval of Amtagvi for advanced melanoma

Jun 3, 2026, 4:05 PM EDT - 3 months ago

Iovance's Amtagvi® (lifileucel) Granted Approval for the Treatment of Advanced Melanoma in Australia

2026-06-01T13:15:52.000Z - 3 months ago

Iovance gets allowance to proceed from FDA for IOV-5001 IND application

Jun 1, 2026, 7:30 AM EDT - 3 months ago

Iovance Biotherapeutics Announces Clearance of Investigational New Drug (IND) Application for IL-12 Tethered TIL Therapy IOV-5001

May 21, 2026, 8:05 AM EDT - 3 months ago

Iovance Biotherapeutics to Present at Upcoming Conference

2026-05-08T00:11:03.000Z - 4 months ago

Iovance Biotherapeutics price target lowered to $14 from $16 at Chardan

2026-05-07T13:16:25.000Z - 4 months ago

Iovance Biotherapeutics reports Q1 EPS (19c), consensus (15c)

2026-05-07T13:15:56.000Z - 4 months ago

Iovance Biotherapeutics sees Q2 revenue $86M-$88M, consensus $84.36M

2026-05-07T13:14:41.000Z - 4 months ago

Iovance Biotherapeutics sees FY26 revenue $350M-$370M, consensus $359.68M

May 7, 2026, 8:30 AM EDT - 4 months ago

Iovance Biotherapeutics Earnings Call Transcript: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 months ago

Iovance Biotherapeutics Earnings release: Q1 2026

May 7, 2026, 8:30 AM EDT - 4 months ago

Iovance Biotherapeutics Quarterly report: Q1 2026

May 7, 2026, 7:05 AM EDT - 4 months ago

Iovance Biotherapeutics Highlights Positive First Quarter 2026 Results, Business Achievements and Corporate Updates

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Iovance Biotherapeutics Proxy statement: Proxy filing

Apr 28, 2026, 8:00 AM EDT - 4 months ago

Iovance Biotherapeutics Proxy statement: Proxy filing

Apr 27, 2026, 8:01 AM EDT - 4 months ago

Iovance Biotherapeutics to Report First Quarter 2026 Financial Results and Corporate Updates on Thursday, May 7, 2026

Apr 17, 2026, 8:00 AM EDT - 4 months ago

Iovance Biotherapeutics Proxy statement: Proxy filing

2026-04-10T17:43:13.000Z - 5 months ago

Replimune CRL positive for Iovance in near-term, says Chardan

REPL

Mar 11, 2026, 9:30 AM EDT - 6 months ago

Iovance Biotherapeutics Transcript: Barclays 28th Annual Global Healthcare Conference

Mar 2, 2026, 9:50 AM EST - 6 months ago

Iovance Biotherapeutics Transcript: TD Cowen 46th Annual Health Care Conference

Feb 26, 2026, 8:00 AM EST - 6 months ago

Iovance Biotherapeutics to Present at Upcoming Conferences

Feb 24, 2026, 8:30 AM EST - 6 months ago

Iovance Biotherapeutics Earnings Call Transcript: Q4 2025

Feb 24, 2026, 8:30 AM EST - 6 months ago

Iovance Biotherapeutics Annual report: Q4 2025

Feb 24, 2026, 8:30 AM EST - 6 months ago

Iovance Biotherapeutics Earnings release: Q4 2025

Feb 24, 2026, 7:00 AM EST - 6 months ago

Iovance Biotherapeutics Highlights Strong Fourth Quarter and Full Year 2025 Results, Business Achievements and Corporate Updates

Feb 24, 2026, 7:00 AM EST - 6 months ago

Iovance Announces Positive Results from the First Clinical Trial for TIL Cell Therapy in Soft Tissue Sarcomas

Feb 24, 2026, 7:00 AM EST - 6 months ago

Iovance Biotherapeutics Slides: Corporate presentation

Feb 11, 2026, 4:05 PM EST - 7 months ago

Iovance Biotherapeutics to Report Fourth Quarter and Full Year 2025 Financial Results and Corporate Updates on Tuesday, February 24, 2026

Feb 5, 2026, 5:15 PM EST - 7 months ago

Best-in-Class Real-World Data Support Early Amtagvi® Treatment in Advanced Melanoma

Jan 9, 2026, 7:00 AM EST - 8 months ago

Iovance Biotherapeutics Slides: Corporate presentation

Nov 6, 2025, 8:30 AM EST - 10 months ago

Iovance Biotherapeutics Earnings Call Transcript: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Iovance Biotherapeutics Quarterly report: Q3 2025

Nov 6, 2025, 8:30 AM EST - 10 months ago

Iovance Biotherapeutics Earnings release: Q3 2025

Sep 9, 2025, 11:00 AM EDT - 1 year ago

Iovance Biotherapeutics Transcript: H.C. Wainwright 27th Annual Global Investment Conference

Sep 5, 2025, 8:00 AM EDT - 1 year ago

Iovance Biotherapeutics Transcript: Wells Fargo 20th Annual Healthcare Conference 2025

Aug 18, 2025, 4:15 PM EDT - 1 year ago

Iovance's Amtagvi® (lifileucel) Receives Health Canada Approval for Advanced Melanoma

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Iovance Biotherapeutics Earnings Call Transcript: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Iovance Biotherapeutics Quarterly report: Q2 2025

Aug 7, 2025, 4:30 PM EDT - 1 year ago

Iovance Biotherapeutics Earnings release: Q2 2025

Aug 7, 2025, 4:01 PM EDT - 1 year ago

Iovance Biotherapeutics Reports Financial Results and Corporate Updates for Second Quarter and First Half 2025

Jul 23, 2025, 12:08 PM EDT - 1 year ago

Here's why Iova stock surged 32% today and why the rally might not be over

Jul 15, 2025, 7:30 AM EDT - 1 year ago

Iovance Biotherapeutics Appoints Corleen Roche as Chief Financial Officer

Jul 14, 2025, 9:04 AM EDT - 1 year ago

IOVA Shareholders Have the Right to Lead the Iovance Biotherapeutics, Inc. Securities Lawsuit - Contact the DJS Law Group to Discuss Your Rights - ELV

Jul 14, 2025, 7:30 AM EDT - 1 year ago

Real-World Data Demonstrate a 49% Response Rate for Commercial Amtagvi® in Patients with Advanced Melanoma

Jul 10, 2025, 4:01 PM EDT - 1 year ago

Iovance Biotherapeutics Appoints Marc R. Theoret, M.D.

Jul 10, 2025, 8:18 AM EDT - 1 year ago

IOVA COURT NOTICE: Iovance Biotherapeutics Investors may have been Affected by Fraud – Contact BFA Law by the July 14 Legal Deadline (NASDAQ:IOVA)

Jun 28, 2025, 7:46 AM EDT - 1 year ago

IOVA INVESTOR DEADLINE: Iovance Biotherapeutics Investors with Losses may have been Affected by Fraud – Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 20, 2025, 9:07 AM EDT - 1 year ago

IOVA COURT REMINDER: Iovance Biotherapeutics, Inc. Investors that Lost Money may have been Affected by Fraud -- Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

Jun 18, 2025, 8:38 AM EDT - 1 year ago

IOVA NOTICE: Did Iovance Biotherapeutics, Inc. Mislead Investors? Contact BFA Law by July 14 Court Deadline if You Suffered Losses (NASDAQ:IOVA)

Jun 16, 2025, 8:17 AM EDT - 1 year ago

IOVA SHAREHOLDER REPORT: Iovance Biotherapeutics, Inc. was Sued for Fraud – Investors with Losses are Notified to Contact BFA Law by July 14 Court Deadline (NASDAQ:IOVA)

bigdog85 Aug. 29 at 1:03 AM

$IOVA 🔥

2 · Reply

dogbone98 Aug. 29 at 12:20 AM

$IOVA Checked the IOVA job board and it looks like they filled two Regulatory positions, including Director. Also added 4 production positions.

0 · Reply

sck2 Aug. 28 at 11:15 PM

2 · Reply

Cfl41m Aug. 28 at 10:49 PM

$IOVA

0 · Reply

Cfl41m Aug. 28 at 10:48 PM

$IOVA

0 · Reply

Fire_Truck Aug. 28 at 10:15 PM

$IOVA https://simplywall.st/stocks/us/pharmaceuticals-biotech/nasdaq-iova/iovance-biotherapeutics/news/iovance-biotherapeutics-iova-wins-fda-trial-clearance-is-the

1 · Reply

FoundMuhMoney Aug. 28 at 9:23 PM

$IOVA Sometimes ya add just to add.. 🤷🏻‍♂️

2 · Reply

dogbone98 Aug. 28 at 8:30 PM

$IOVA Looking at the 6 month graph, next week looks poised to head to either $7 or $9. I'll take flatline too, but don't want 7's.

2 · Reply

JoeBio Aug. 28 at 8:21 PM

2 · Reply

sck2 Aug. 28 at 8:15 PM

$IOVA don't let the stock stop you from celebrating your dinner, jmo and enjoy your weekend.

1 · Reply

stock2retire Aug. 28 at 8:09 PM

$IOVA glad we are in 8.X than 1.X or 3.X..have confidence on the upcoming catalysts, we will fly soon... My journey with IOVA 8 -7-6-5-4-3-2-1-2-3-4-5-6-7-8

0 · Reply

RunsWithDogs Aug. 28 at 8:06 PM

$IOVA I know volume was low and the price still held 8, so I should be satisfied. However, it does really suck to have that decline happen on a Friday! I was really hoping to do a celebration dinner at a favorite restaurant. Next week perhaps...🤷‍♂️

3 · Reply

sck2 Aug. 28 at 8:05 PM

$IOVA 💪🐂

0 · Reply

WhoisHenry Aug. 28 at 8:04 PM

$IOVA Nothing smells quite like the smell of dead options. MM’s pinned us to 8 all day today.

2 · Reply

Mariorx Aug. 28 at 7:59 PM

$IOVA fill me please

1 · Reply

Magnificient Aug. 28 at 7:57 PM

$IOVA hope over 8. And shorties will loose

0 · Reply

Midnitedynamite Aug. 28 at 7:40 PM

$SLS $IOVA $IBRX Time to break my old friend Warren. Plus a little bonus for the Market Makers and shorts!

1 · Reply

fffagygfcqdvc Aug. 28 at 7:34 PM

$IOVA I do not care. I will buy.

0 · Reply

dogbone98 Aug. 28 at 7:27 PM

$IOVA Might not even make it to yesterday's volume. Feeling like we could get a PR next week sometime. Maybe give the lung oncos something to discuss at WCLC (Sept 12-15). 4 months left in 2026 and still waiting on rev guidance, 4001/5001, Endo, Switz approval, EMA resubmittal, and of course LUN, not to mention things we don't know about.

2 · Reply

Flyingkitty Aug. 28 at 6:58 PM

$IOVA To all a great weekend 😸... (Part of the Grand Canyon)

1 · Reply

sixmilliondollarman Aug. 28 at 6:54 PM

$IOVA XBI ⬇️ 3.5% IOVA ⬇️ 2.5% There was a time when IOVA would be down 2X the XBI. New times!

2 · Reply

PensionPulse Aug. 28 at 6:51 PM

$IOVA Jackson Hole nonsense today, with Watch talking up risks of inflation. He won’t raise rates, on same page as Bessent and Trump. Hate these Fed days, pure nonsense. As for Iovance, get on with guidance already!

0 · Reply

Market Cap	3.74B
Revenue (ttm)	263.50M
Net Income (ttm)	-390.98M
EPS (ttm)	N/A
PE Ratio	0.00
Forward PE	N/A
Profit Margin	-148.38%
Debt to Equity Ratio	0.00

Volume	7,693,300
Avg Vol	17,574,125
Day's Range	N/A - N/A
Shares Out	452.97M
Stochastic %K	44%
Beta	0.71
Analysts	Strong Sell
Price Target	$9.55